Stay updated on Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial
Sign up to get notified when there's something new on the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page.

Latest updates to the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe Record History now adds a new Revision: v3.5.3 entry, reflecting a recent site update to the page's UI. The previous revision v3.5.2 is superseded.SummaryDifference0.1%

- Check15 days agoChange DetectedUpdated the trial’s study and recruitment status from **Recruiting** to **Active, not recruiting**, with related record updates dated **2026-04-16** and **2026-04-20**.SummaryDifference0.6%

- Check22 days agoChange DetectedAdded a new site revision entry Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.5.0 to the history and removed Revision: v3.4.3. This reflects an update to the page's revision tracking system.SummaryDifference0.1%

- Check58 days agoChange DetectedThe record history shows a new revision entry v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check86 days agoChange DetectedA new revision entry 'Revision: v3.4.2' was added to the Study Record Versions list. The previously displayed government funding operating status notice was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

Stay in the know with updates to Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Doxorubicin Plus Checkpoint Blockade in Sarcomas Clinical Trial page.